Year: 2026 | Month: September | Volume: 13 | Issue: 9 | Pages: 456-462
DOI: https://doi.org/10.52403/ijrr.20260943
Impact of Psoriasis on Quality of Life: The Hospital-Based Cross-Sectional Study
Dr Masarat Fatima1, Prof. Tanzeel Ahmad2, Dr Firdous Ahmad3, Dr Saba Ibrahim4, Dr Ayesha Naroon5
1Associate Professor, Dept. of Moalajat (Medicine), Govt. Unani Medical College & Hospital, Bangalore- 560079, India
2Professor of, Dept. of Moalajat (Medicine), A. K. Tibbiya College, Aligarh Muslim University, Aligarh, India.
3Associate Professor, HoD, Jarahat (Surgery), National Institute of Unani Medicine, Bangalore-560091, India.
4PG Scholar of Department, Amraz-e-Jild wa Tazeeniyat, National Institute of Unani Medicine, Bangalore-560091, India.
5PG Scholar of Department, Amraz-e-Jild wa Tazeeniyat, Govt. Unani Medical College & Hospital, Bangalore- 560079, India
Corresponding Author: Dr Saba Ibrahim
ABSTRACT
Background: Psoriasis is a chronic immune-mediated inflammatory disease that can substantially impair physical, psychological, social, and occupational well-being, resulting in reduced quality of life (QoL).
Objectives: To assess QoL among patients with mild-to-moderate psoriasis and examine its association with age, disease duration, and disease severity.
Methods: This hospital-based cross-sectional study included 70 adults aged 18–65 years with mild-to-moderate psoriasis attending the outpatient clinic between July 2016 and April 2017. QoL was assessed using the Dermatology Life Quality Index (DLQI), while disease severity was evaluated using the Psoriasis Area and Severity Index (PASI). Associations between DLQI scores and demographic and clinical variables were analysed using Pearson’s correlation coefficient and appropriate statistical tests. A P-value <0.05 was considered statistically significant.
Results: The mean age of participants was 41.24 ± 11.56 years, with a mean disease duration of 5.09 ± 5.30 years. The mean DLQI score was 9.63, indicating a moderate effect on QoL. All participants experienced some degree of QoL impairment; 45% reported a very large effect and 3.3% reported an extremely large effect on their lives. DLQI scores showed no significant association with age, disease duration, or PASI score. However, female participants had higher DLQI scores than males.
Limitations: The single-centre setting, relatively small sample size, and cross-sectional design limit generalisability and preclude assessment of temporal changes or causal relationships. Although data were collected during 2016–2017, validated DLQI and PASI instruments support the continued relevance of the findings.
Conclusion: Mild-to-moderate psoriasis significantly affects QoL irrespective of clinical severity. Routine QoL assessment alongside clinical evaluation may facilitate more comprehensive, patient-centred care, particularly among women.
Keywords: Psoriasis; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Quality of Life; Cross-sectional study.
[PDF Full Text]